← Open Payments lookup

BYRON FUSELIER: Open Payments

NPI 1225746597 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,385 in 50 payments from 11 companies in 2025. Trend: 2023 $400 · 2024 $1,058 · 2025 $1,385

Food & beverage: $1,385
CompanyPaymentsAmount
Alnylam Pharmaceuticals Inc.7$209
BridgeBio Pharma, Inc.7$192
AstraZeneca Pharmaceuticals LP9$179
Merck Sharp & Dohme LLC8$162
Boehringer Ingelheim Pharmaceuticals, Inc.7$148
CVRx, Inc.3$132
Veloxis Pharmaceuticals, Inc.2$127
SCPHARMACEUTICALS INC.3$98
Kestra Medical Technology Services, Inc.2$88
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)1$25

Products named: AMVUTTRA, Attruby, JARDIANCE, WAINUA, Barostim Neo System, ENVARSUS, VERQUVO, FUROSCIX.

Industry payments across NY — which companies pay providers there.